Abstract:Ethnopharmacological relevance: Catalpol is made from the root of Rehmannia glutinosa, a plant often used to treat a variety of diseases of the central nervous system in traditional Chinese medicine, such as Dementia, Apoplexy and Parkinson. According to the recent studies, catalpol can attenuate nerve damage by inhibiting neuroinflammation.Aim of the study: In this research, we examined catalopol's impact on neuroinflammation in LPS-induced BV2 cells, ulteriorly assessed the mechanism of the inflammasome.Materials and methods: BV2 cells were induced by LPS to build the neuroinflammatory model in vitro. The best time for LPS to induce the initial stage of neuroinflammation was screening by cell viability (CCK-8). Then the successful construction of the model were verified by cell morphology (optical microscope), and release of inflammatory factors (PCR).Further, catalpol was used for neuroinflammation intervention. The best intervention time of catalpol was screening by cell viability (CCK-8). BV2 cells were exposed to LPS and treated with catalpol (10μM, 100μM, 1000μM) for 24h. The better intervention concentration of catalpol against neuroinflammation was determined through cell viability (CCK-8), cell morphology (optical microscope), and release of inflammatory cytokines (IL-6) (PCR). Then the action of catalpol on LPS-induced BV2 cells polarization was evaluated by M1 (CD86) and M2 (CD206) phenotypic markers of BV2 polarization (WB, FCM). Finally, the mechanism of catalpol against neuroinflammation through NLRP3 inflammasome signal pathway was studied. The signal pathway of anti-inflammatory mechanism of catalpol was evaluated by the expression of NLRP3 inflammasome complex proteins (NLRP3、ASC and caspase-1) (WB、IF) and its upstream target (NF-κB) (WB), and its downriver effector inflammatory cytokines (IL-18、IL-1β) (PCR).Results: In contrast to the LPS group, the catalpol group's BV2 cell activity, length and number of cell branches, and production of IL-6 were all obviously attenusted. Moreover, the CD86 expression was enhanced by LPS and inhibited by catalpol, yet there was no discernible impact from CD206 expression. Further investigation revealed that the catalpol group's NF-κB、NLRP3、ASC、caspase-1、IL-18 and IL-1β expression were much lower than that of the model group.Conclusion: Catalpol has anti-inflammatory effect and inhibites the polarization of pro-inflammatory phenotype of microglia, but has no discernible impact on the polarization of anti-inflammatory phenotype. Catalpol attenuates neuroinflammation by preventing the NF-κB/NLRP3 inflammasome signaling path from becoming activated.

Catalpol Inhibits LPS-Induced Neuroinflammation and Alleviates the Activation of NLRP3 Inflammasome in Microglia

Catalpol reduced LPS induced BV2 immunoreactivity through NF-κB/NLRP3 pathways: an in Vitro and in silico study

Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures

Catalpol rescues LPS-induced cognitive impairment via inhibition of NF-Κb-regulated neuroinflammation and up-regulation of TrkB-mediated BDNF secretion in mice

Catalpol rescues cognitive deficits by attenuating amyloid β plaques and neuroinflammation

Catalpol ameliorates CFA-induced inflammatory pain by targeting spinal cord and peripheral inflammation

RhoA/ROCK-2 Pathway Inhibition and Tight Junction Protein Upregulation by Catalpol Suppresses Lipopolysaccaride-Induced Disruption of Blood-Brain Barrier Permeability

Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson’s Disease

Catalpol ameliorates depressive-like behaviors in CUMS mice via oxidative stress-mediated NLRP3 inflammasome and neuroinflammation

Catalpol Restores Lps-Elicited Rat Microcirculation Disorder By Regulation Of A Network Of Signaling Involving Inhibition Of Tlr-4 And Src

Catalpol attenuates ischemic stroke by promoting neurogenesis and angiogenesis via the SDF-1α/CXCR4 pathway

Further pharmacological evidence of the neuroprotective effect of catalpol from Rehmannia glutinosa

Catalpol Ameliorates Sodium Taurocholate-Induced Acute Pancreatitis In Rats Via Inhibiting Activation Of Nuclear Factor Kappa B

Catalpol suppresses osteoclastogenesis and attenuates osteoclast-derived bone resorption by modulating PTEN activity

Catalpol improves impaired neurovascular unit in ischemic stroke rats via enhancing VEGF-PI3K/AKT and VEGF-MEK1/2/ERK1/2 signaling

Natural bear bile powder suppresses neuroinflammation in lipopolysaccharide-treated mice via regulating TGR5/AKT/NF-κB signaling pathway

Catalpol ameliorates psoriasis-like phenotypes via SIRT1 mediated suppression of NF-κB and MAPKs signaling pathways

Catalpol ameliorates LPS-induced endometritis by inhibiting inflammation and TLR4/NF-κB signaling

Antidepressant effect of catalpol on corticosterone-induced depressive-like behavior involves the inhibition of HPA axis hyperactivity, central inflammation and oxidative damage probably via dual regulation of NF-κB and Nrf2

Analyses of Transcriptomics upon IL-1β-Stimulated Mouse Chondrocytes and the Protective Effect of Catalpol through the NOD2/NF-κB/MAPK Signaling Pathway

Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.